SCHEMBL30136726

SCHEMBL30136726

Cc1c([C@@H](C)N)oc2ccc(F)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.42
NPC1 O15118 5/20 0.42
MAPT P10636 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
AKR1B1 P15121 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.38
GABRP O00591 3/20 0.37
GABRD O14764 3/20 0.37
GABRA1 P14867 3/20 0.37
GABRB1 P18505 3/20 0.37
GABRG2 P18507 3/20 0.37
GABRB3 P28472 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20559261 1.00 RAB9A (0.42) RAB9ANPC1MAPTCYP1A2CYP3A4
SCHEMBL24756010 1.00 RAB9A (0.42) RAB9ANPC1MAPTCYP1A2CYP3A4
SCHEMBL20559260 1.00 RAB9A (0.42) RAB9ANPC1MAPTCYP1A2CYP3A4
SCHEMBL30933170 0.87 RAB9A (0.38) RAB9ANPC1MAPTCYP1A2CYP3A4
SCHEMBL24755661 0.87 RAB9A (0.38) RAB9ANPC1MAPTCYP1A2CYP3A4
SCHEMBL24755663 0.87 RAB9A (0.38) RAB9ANPC1MAPTCYP1A2CYP3A4
SCHEMBL24755986 0.87 RAB9A (0.38) RAB9ANPC1MAPTCYP1A2CYP3A4
SCHEMBL30136617 0.87 RAB9A (0.38) RAB9ANPC1MAPTCYP1A2CYP3A4
SCHEMBL12248495 0.86 RAB9A (0.41) RAB9ANPC1MAPTCYP1A2CYP3A4
SCHEMBL24756449 0.83 RAB9A (0.39) RAB9ANPC1MAPTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117813293-A Urea derivatives useful for the treatment of cancer 蝎子疗法股份有限公司 2024-04-02 CN disclosed
EP-4334298-A1 UREA DERIVATIVES WHICH CAN BE USED TO TREAT CANCER Scorpion Therapeutics, Inc. (US) 2024-03-13 EP disclosed
WO-2022265993-A1 UREA DERIVATIVES WHICH CAN BE USED TO TREAT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed